课题基金 / 基金详情

Eukaryotic Elongation Factor-2 Kinase (eEF2K) as a new therapeutic target in pediatric brain cancer

Eukaryotic Elongation Factor-2 Kinase (eEF2K) as a new therapeutic target in pediatric brain cancer
真核延伸因子 2 激酶 (eEF2K) 作为小儿脑癌的新治疗靶点
批准号：
397056
负责人：
Delaidelli Alberto
金额：
$9.83万
依托单位：
BC Cancer, part of PHSA (Vancouver)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-11-01 至 2021-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=397056&lang=en
关键词：
Pediatric Cancer

项目摘要

项目成果

Delaidelli Alberto的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
More than 600,000 people in North America die from cancer each year. Within the scope of people affected by this disease, brain cancer is the most common pediatric solid cancer, devastating the lives of more than 4,600 children and their families every ye
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of CAR T cell-based immunotherapy for high risk medulloblastoma informed by membrane proteomics
  • 批准号：
    454536
  • 项目类别：
    Fellowship Programs
  • 资助金额：
    $1.09万
  • 财政年份：
    2021
  • 负责人：
    Delaidelli Alberto
  • 依托单位：
    BC Cancer, part of PHSA (Vancouver)
Targeting metabolic adaptation in MYC driven medulloblastoma
Role of the let7-eEF2K axis in MYC-driven Medulloblastoma Adaptation to Nutrient Deprivation
Targeting metabolic adaptation in MYC driven pediatric neuronal tumors
海外基金